Christopher Dewey - Medtech Acquisition CEO Director
| MTACUDelisted Stock | USD 9.86 0.00 0.00% |
Insider
Christopher Dewey is CEO Director of Medtech Acquisition Corp
| Age | 79 |
| Phone | 908 391 1288 |
Medtech Acquisition Management Efficiency
The company has return on total asset (ROA) of (0.0193) % which means that it has lost $0.0193 on every $100 spent on assets. This is way below average. Medtech Acquisition's management efficiency ratios could be used to measure how well Medtech Acquisition manages its routine affairs as well as how well it operates its assets and liabilities.Medtech Acquisition Corp has accumulated 2.37 M in total debt with debt to equity ratio (D/E) of 1.77, which is about average as compared to similar companies. Medtech Acquisition Corp has a current ratio of 0.15, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about Medtech Acquisition's use of debt, we should always consider it together with its cash and equity.
MedTech Acquisition Corporation does not have significant operations. The company was incorporated in 2020 and is based in Greenwich, Connecticut. Medtech Acquisition is traded on NASDAQ Exchange in the United States. Medtech Acquisition Corp (MTACU) is traded on NASDAQ Exchange in USA and employs 3 people. Management Performance
| Return On Asset | -0.0193 |
Medtech Acquisition Corp Management Team
Elected by the shareholders, the Medtech Acquisition's board of directors comprises two types of representatives: Medtech Acquisition inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medtech. The board's role is to monitor Medtech Acquisition's management team and ensure that shareholders' interests are well served. Medtech Acquisition's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medtech Acquisition's outside directors are responsible for providing unbiased perspectives on the board's policies.
| David JD, CFO Director | ||
| Christopher Dewey, CEO Director | ||
| Robert JD, Chief Sec |
Medtech Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Medtech Acquisition a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.0193 | |||
| Current Valuation | 81.09 M | |||
| Price To Earning | 39.61 X | |||
| EBITDA | (8.58 M) | |||
| Net Income | 5.54 M | |||
| Cash And Equivalents | 69.18 K | |||
| Total Debt | 2.37 M | |||
| Debt To Equity | 1.77 % | |||
| Current Ratio | 0.15 X | |||
| Book Value Per Share | (2.42) X |
Thematic Opportunities
Explore Investment Opportunities
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in Medtech Stock
If you are still planning to invest in Medtech Acquisition Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medtech Acquisition's history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |